查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609979

鐮狀細胞貧血檢測和篩檢市場規模、佔有率、趨勢分析報告：按技術、按年齡層、按行業類型、按地區、細分市場預測，2025-2030 年

Sickle Cell Anemia Testing And Screening Market Size, Share & Trends Analysis Report By Technology (Hemoglobin Electrophoresis, Point-of-Care Tests), By Age Group, By Sector Type, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

鐮狀細胞貧血檢測和篩檢市場成長和趨勢

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球鐮狀貧血檢測和篩檢市場規模預計將達到 8.295 億美元，2025 年至 2030 年複合年成長率為 12.1%。血紅素 S (HbS) 是鐮狀細胞疾病的病原體，鐮狀細胞疾病是目前全球最受歡迎的疾病或遺傳異常，特別是在新興經濟體。

鐮狀細胞血紅素的變異體包括 HbS、HbA 和 HbC。已經開發了各種測試來清楚地區分上述所有三種血紅蛋白變體。深度學習框架的開發旨在透過智慧型手機顯微鏡從患者血液抹片樣本中自動篩檢鐮狀細胞性貧血，這可能會在不久的將來為市場開闢新的途徑。

市場適度整合，主要市場參與企業努力透過聯盟和收購維持市場競爭，並擴大在新生兒檢測市場的業務。同時，新興企業正在探索就地檢驗的潛力，以贏得市場競爭。

血紅蛋白電泳和高效液相層析法在政府主導的新生兒篩檢計畫和評估研究中的使用正在迅速增加，導致市場滲透率的提高。因此，它引起了渴望改進現有產品線的公司的注意，進一步增加了產品的消費。

鐮狀細胞性貧血檢測和篩檢市場報告亮點

  • 按年齡層別分類，世界各地已採用多種新生兒篩檢計劃，以有效控制這種疾病的負擔。這些程序利用各種測試，包括等電聚焦/醋酸纖維素電泳、高效液相層析(HPLC) 和溶解度測試。
  • 從技術上來看，POC橫向流動化驗是篩檢計畫中首選的檢測方法，構成了傳統的檢測工具。
  • 按部門類型分類，政府實驗室長期以來一直是鐮狀細胞檢測的最大採用者。
  • 政府實驗室正在積極參與透過鼓勵基於鐮狀的鐮狀細胞檢測來促進這些檢測的採用。
  • 對聯邦和基金會資金的需求不斷增加，以解決血紅蛋白病和囊腫纖維化等疾病的治療和診斷方面的醫療保健差異，預計將引起監管機構的關注。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章鐮狀細胞貧血症檢測和篩檢市場變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 營商環境分析
    • 產業分析-波特五力分析
    • PESTLE分析

第4章鐮狀細胞性貧血檢測與篩檢市場：依技術、商業分析

  • 2024 年和 2030 年按技術分類的市場佔有率
  • 技術板塊細分儀表板
  • 2018-2030 年按技術分類的市場規模、預測與趨勢分析
  • 血紅素電泳
  • 高效液相層析（HPLC）
  • 就地檢驗
  • 其他

第5章鐮狀細胞性貧血檢測與篩檢市場：依年齡層、業務分析

  • 2024 年及 2030 年按年齡層分類的市場佔有率
  • 年齡層細分儀表板
  • 2018-2030 年市場規模、預測與趨勢分析（按行業類型）
  • 新生兒篩檢（12個月以下）
  • 成人篩檢（25-60歲）
  • 其他（1-25歲及60歲以上）

第6章鐮狀細胞性貧血檢測與篩檢市場：依產業類型、業務分析

  • 2024 年和 2030 年按行業類型分類的市場佔有率
  • 按部門類型細分儀表板
  • 2018-2030 年市場規模、預測與趨勢分析（按行業類型）
  • 政府實驗室
  • 私人實驗室
  • 企業實驗室
  • PPP（官民合作關係）

第7章鐮狀細胞性貧血檢測和篩檢市場：按技術、按地區、估計和趨勢分析

  • 2024 年及 2030 年按地區分類的市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 按國家/地區分類，2018-2030
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 按國家/地區分類，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 按國家/地區分類，2018-2030
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 按國家/地區分類，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章鐮狀細胞性貧血檢測和篩檢市場：按年齡層、地區、估計和趨勢分析

  • 2024 年及 2030 年按地區分類的市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 按國家/地區分類，2018-2030
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 按國家/地區分類，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 按國家/地區分類，2018-2030
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 按國家/地區分類，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第 9 章鐮狀細胞貧血症檢測和篩檢市場：按行業類型、按地區、估計和趨勢分析

  • 2024 年及 2030 年按地區分類的市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 按國家/地區分類，2018-2030
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 按國家/地區分類，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
Product Code: GVR-4-68038-761-2

Sickle Cell Anemia Testing And Screening Market Growth & Trends:

The global sickle cell anemia testing and screening market size is expected to reach USD 829.5 million by 2030, expanding at a CAGR of 12.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Hemoglobin S (HbS) is the causative factor for sickle cell disease and is currently the most prevailing disease or genetic abnormality across the globe, specifically across developing economies.

Sickle cell hemoglobin variants are inclusive of HbS, HbA, and HbC. Different tests have been developed to perform a clear distinction between all the three above-mentioned hemoglobin variants. Development of a deep learning framework designed to perform automated screening of sickle cell anemia in blood smear sample of patients via a smartphone microscope is set to open up new avenues for the market in the near future.

The market is moderately consolidated, wherein the key industry participants are striving to sustain market competition via partnerships, acquisitions, and expanding their business across newborn testing market space. Whereas, emerging companies are exploring potential of point-of-care tests to gain a competitive edge in the market.

A steep increase in the uptake of Hb electrophoresis and HPLC across government-initiated newborn screening programs and assessment studies have resulted in robust market penetration. This has, in turn, caught the attention of companies who are keen on modifying their existing product line, further amplifying consumption of the same.

Sickle Cell Anemia Testing And Screening Market Report Highlights:

  • By age group, several newborn screening programs have been employed across the globe to effectively manage the burden of this disease. These programs make use of different tests such as isoelectric focusing/ cellulose acetate electrophoresis, high-performance liquid chromatography (HPLC), and solubility tests
  • Based on technology, POC lateral flow assays are the most preferred testing methodologies in screening programs, forming the conventional means of testing
  • On the basis of sector type, government laboratories have witnessed maximum employment of sickle cell tests over the years
  • Government laboratories have actively participated in promoting the adoption of these tests by encouraging population-based sickle cell testing
  • Rise in the demand for federal and foundation funding to address healthcare disparities treatments and diagnosis of diseases, such as hemoglobinopathies and cystic fibrosis, is expected to drive the attention of the regulatory agencies.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Age Group
    • 1.2.3. Sector Type
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Sickle Cell Anemia Testing & Screening Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Sickle Cell Anemia Testing & Screening Market: Technology Business Analysis

  • 4.1. Technology Market Share, 2024 & 2030
  • 4.2. Technology Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 4.4. Hemoglobin Electrophoresis
    • 4.4.1. Hemoglobin Electrophoresis Market, 2018 - 2030 (USD Million)
    • 4.4.2. Isoelectric Focusing
      • 4.4.2.1. Isoelectric Focusing Market, 2018 - 2030 (USD Million)
    • 4.4.3. Others
      • 4.4.3.1. Others Market, 2018 - 2030 (USD Million)
  • 4.5. High-Performance Liquid Chromatography (HPLC)
    • 4.5.1. High-Performance Liquid Chromatography (HPLC) Market, 2018 - 2030 (USD Million)
  • 4.6. Point-of-Care Tests
    • 4.6.1. Point-of-Care Tests Market, 2018 - 2030 (USD Million)
    • 4.6.2. Lateral Flow Immunoassay
      • 4.6.2.1. Lateral Flow Immunoassay Market, 2018 - 2030 (USD Million)
    • 4.6.3. Paper-Based Rapid Diagnostics
      • 4.6.3.1. Paper-Based Rapid Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.6.4. Others
      • 4.6.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.7. Other Tests
    • 4.7.1. Other Tests Market, 2018 - 2030 (USD Million)

Chapter 5. Sickle Cell Anemia Testing & Screening Market: Age Group Business Analysis

  • 5.1. Age Group Market Share, 2024 & 2030
  • 5.2. Age Group Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Age Group, 2018 to 2030 (USD Million)
  • 5.4. Newborn Screening (12 months and below)
    • 5.4.1. Newborn Screening (12 months and below) Market, 2018 - 2030 (USD Million)
  • 5.5. Adult Screening (25 to 60 years)
    • 5.5.1. Adult Screening (25 to 60 years) Market, 2018 - 2030 (USD Million)
  • 5.6. Other Age Groups (1 to 25 & above 60 years)
    • 5.6.1. Other Age Groups (1 to 25 & above 60 years) Market, 2018 - 2030 (USD Million)

Chapter 6. Sickle Cell Anemia Testing & Screening Market: Sector Type Business Analysis

  • 6.1. Sector Type Market Share, 2024 & 2030
  • 6.2. Sector Type Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Sector Type, 2018 to 2030 (USD Million)
  • 6.4. Government Labs
    • 6.4.1. Government Labs Market, 2018 - 2030 (USD Million)
  • 6.5. Private Labs
    • 6.5.1. Private Labs Market, 2018 - 2030 (USD Million)
  • 6.6. Corporate Labs
    • 6.6.1. Corporate Labs Market, 2018 - 2030 (USD Million)
  • 6.7. PPP (Public-Private-Partnerships)
    • 6.7.1. PPP (Public-Private-Partnerships) Market, 2018 - 2030 (USD Million)

Chapter 7. Sickle Cell Anemia Testing & Screening Market: Regional Estimates & Trend Analysis by Technology

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Sickle Cell Anemia Testing & Screening Market: Regional Estimates & Trend Analysis by Age Group

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Framework
      • 8.4.2.3. Competitive Insights
      • 8.4.2.4. U.S. Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework
      • 8.4.3.3. Competitive Insights
      • 8.4.3.4. Canada Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Regulatory Framework
      • 8.4.4.3. Competitive Insights
      • 8.4.4.4. Mexico Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Framework
      • 8.5.2.3. Competitive Insights
      • 8.5.2.4. UK Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework
      • 8.5.3.3. Competitive Insights
      • 8.5.3.4. Germany Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework
      • 8.5.4.3. Competitive Insights
      • 8.5.4.4. France Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework
      • 8.5.5.3. Competitive Insights
      • 8.5.5.4. Italy Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework
      • 8.5.6.3. Competitive Insights
      • 8.5.6.4. Spain Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework
      • 8.5.7.3. Competitive Insights
      • 8.5.7.4. Norway Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework
      • 8.5.8.3. Competitive Insights
      • 8.5.8.4. Denmark Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Sweden
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Regulatory Framework
      • 8.5.9.3. Competitive Insights
      • 8.5.9.4. Sweden Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Framework
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. Japan Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. China Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework
      • 8.6.4.3. Competitive Insights
      • 8.6.4.4. India Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework
      • 8.6.5.3. Competitive Insights
      • 8.6.5.4. South Korea Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. Australia
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Regulatory Framework
      • 8.6.6.3. Competitive Insights
      • 8.6.6.4. Australia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Regulatory Framework
      • 8.6.7.3. Competitive Insights
      • 8.6.7.4. Thailand Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Framework
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. Brazil Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Framework
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Argentina Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Framework
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. South Africa Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Framework
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Saudi Arabia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Framework
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. UAE Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Framework
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Kuwait Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Sickle Cell Anemia Testing & Screening Market: Regional Estimates & Trend Analysis by Sector Type

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. North America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Framework
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. U.S. Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Framework
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Canada Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Framework
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. Mexico Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Framework
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. UK Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Framework
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Germany Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Regulatory Framework
      • 9.5.4.3. Competitive Insights
      • 9.5.4.4. France Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Regulatory Framework
      • 9.5.5.3. Competitive Insights
      • 9.5.5.4. Italy Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Regulatory Framework
      • 9.5.6.3. Competitive Insights
      • 9.5.6.4. Spain Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.7. Norway
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Regulatory Framework
      • 9.5.7.3. Competitive Insights
      • 9.5.7.4. Norway Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.8. Denmark
      • 9.5.8.1. Key Country Dynamics
      • 9.5.8.2. Regulatory Framework
      • 9.5.8.3. Competitive Insights
      • 9.5.8.4. Denmark Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.9. Sweden
      • 9.5.9.1. Key Country Dynamics
      • 9.5.9.2. Regulatory Framework
      • 9.5.9.3. Competitive Insights
      • 9.5.9.4. Sweden Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Framework
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. Japan Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Framework
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. China Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Framework
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. India Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. South Korea
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Framework
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. South Korea Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.6. Australia
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. Regulatory Framework
      • 9.6.6.3. Competitive Insights
      • 9.6.6.4. Australia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key Country Dynamics
      • 9.6.7.2. Regulatory Framework
      • 9.6.7.3. Competitive Insights
      • 9.6.7.4. Thailand Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 4. Global sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 5. Global sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 6. Global sickle cell anemia testing & screening market, by region, 2018 - 2030 (USD Million)
  • Table 7. North America sickle cell anemia testing & screening market, by country, 2018 - 2030 (USD Million)
  • Table 8. North America sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 9. North America sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 10. North America sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 11. U.S. sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 12. U.S. sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 13. U.S. sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 14. Canada sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 15. Canada sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 16. Canada sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 17. Mexico sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 18. Mexico sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 19. Mexico sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 20. Europe sickle cell anemia testing & screening market, by country, 2018 - 2030 (USD Million)
  • Table 21. Europe sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 22. Europe sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 23. Europe sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 24. UK sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 25. UK sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 26. UK sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 27. Germany sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 28. Germany sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 29. Germany sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 30. France sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 31. France sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 32. France sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 33. Italy sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 34. Italy sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 35. Italy sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 36. Spain sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 37. Spain sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 38. Spain sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 39. Norway sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 40. Norway sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 41. Norway sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 42. Denmark sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 43. Denmark sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 44. Denmark sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 45. Sweden sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 46. Sweden sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 47. Sweden sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific sickle cell anemia testing & screening market, by country, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 51. Asia Pacific sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 52. Japan sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 53. Japan sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 54. Japan sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 55. China sickle cell anemia testing & screening market, by technology, 2018-2030 (USD Million)
  • Table 56. China sickle cell anemia testing & screening market, by age group, 2018-2030 (USD Million)
  • Table 57. China sickle cell anemia testing & screening market, by sector type, 2018-2030 (USD Million)
  • Table 58. India sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 59. India sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 60. India sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 61. Australia sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 62. Australia sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 63. Australia sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 64. South Korea sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 65. South Korea sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 66. South Korea sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 67. Thailand sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 68. Thailand sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 69. Thailand sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 70. Latin America sickle cell anemia testing & screening market, by country, 2018 - 2030 (USD Million)
  • Table 71. Latin America sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 72. Latin America sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million
  • Table 73. Latin America sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million
  • Table 74. Brazil sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 75. Brazil sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 76. Brazil sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 77. Argentina sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 78. Argentina sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 79. Argentina sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa sickle cell anemia testing & screening market, by country, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 83. Middle East & Africa sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 84. South Africa sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 85. South Africa sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 86. South Africa sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 90. UAE sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 91. UAE sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 92. UAE sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 93. Kuwait sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 94. Kuwait sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 95. Kuwait sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Sickle cell anemia testing & screening market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Technology outlook (USD Million)
  • Fig. 10 Transportation mode outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Sickle cell anemia testing & screening market dynamics
  • Fig. 13 Sickle cell anemia testing & screening market: Porter's five forces analysis
  • Fig. 14 Sickle cell anemia testing & screening market: PESTLE analysis
  • Fig. 15 Sickle cell anemia testing & screening market: Technology segment dashboard
  • Fig. 16 Sickle cell anemia testing & screening market: Technology market share analysis, 2024 & 2030
  • Fig. 17 Hemoglobin electrophoresis market, 2018 - 2030 (USD Million)
  • Fig. 18 High-performance liquid chromatography (HPLC) market, 2018 - 2030 (USD Million)
  • Fig. 19 Point-of-care tests market, 2018 - 2030 (USD Million)
  • Fig. 20 Other tests market, 2018 - 2030 (USD Million)
  • Fig. 21 Sickle cell anemia testing & screening market: Age Group segment dashboard
  • Fig. 22 Sickle cell anemia testing & screening market: Age Group market share analysis, 2024 & 2030
  • Fig. 23 Newborn screening (12 months and below) market, 2018 - 2030 (USD Million)
  • Fig. 24 Adult screening (25 to 60 years) market, 2018 - 2030 (USD Million)
  • Fig. 25 Other age groups (1 to 25 & above 60 years) market, 2018 - 2030 (USD Million)
  • Fig. 26 Sickle cell anemia testing & screening market: Sector type segment dashboard
  • Fig. 27 Sickle cell anemia testing & screening market: Sector type market share analysis, 2024 & 2030
  • Fig. 28 Government labs market, 2018 - 2030 (USD Million)
  • Fig. 29 Private labs market, 2018 - 2030 (USD Million)
  • Fig. 30 Corporate labs market, 2018 - 2030 (USD Million)
  • Fig. 31 PPP (public private partnerships) market, 2018 - 2030 (USD Million)
  • Fig. 32 Sickle cell anemia testing & screening market revenue, by region
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 North America sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. country dynamics
  • Fig. 36 U.S. sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada country dynamics
  • Fig. 38 Canada sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 39 Mexico country dynamics
  • Fig. 40 Mexico sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 42 UK country dynamics
  • Fig. 43 UK sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany country dynamics
  • Fig. 45 Germany sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 46 France country dynamics
  • Fig. 47 France sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy country dynamics
  • Fig. 49 Italy sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 50 Spain country dynamics
  • Fig. 51 Spain sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway country dynamics
  • Fig. 53 Norway sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden country dynamics
  • Fig. 55 Sweden sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark country dynamics
  • Fig. 57 Denmark sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan country dynamics
  • Fig. 60 Japan sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 61 China country dynamics
  • Fig. 62 China sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 63 India country dynamics
  • Fig. 64 India sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 65 Australia country dynamics
  • Fig. 66 Australia sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 67 South Korea country dynamics
  • Fig. 68 South Korea sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 69 Thailand country dynamics
  • Fig. 70 Thailand sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 71 Latin America sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 72 Brazil country dynamics
  • Fig. 73 Brazil sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 74 Argentina country dynamics
  • Fig. 75 Argentina sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 76 MEA sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 77 South Africa country dynamics
  • Fig. 78 South Africa sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 79 Saudi Arabia country dynamics
  • Fig. 80 Saudi Arabia sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 81 UAE country dynamics
  • Fig. 82 UAE sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 83 Kuwait country dynamics
  • Fig. 84 Kuwait sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 85 Company categorization
  • Fig. 86 Company market position analysis
  • Fig. 87 Strategic framework